 |
 |
|
|
RESÚMENES OCTUBRE 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la
información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
3! -
Relationship between gross domestic product and duration of untreated psychosis
in low- and middle-income countries
Matthew Large, Saeed Farooq, Olav Nielssen, Tim Slade
The British Journal of Psychiatry (2008) 193:
272-278
4< - Extrapyramidal side-effects of antipsychotics in a
randomised trial
Del D. Miller, Stanley N. Caroff, Sonia M.
Davis, Robert A. Rosenheck, Joseph P. McEvoy, Bruce L. Saltz, Silvana Riggio, Miranda H. Chakos, Marvin S. Swartz, Richard S. E. Keefe, T. Scott
Stroup, Jeffrey A. Lieberman, the Clinical Antipsychotic Trials of Intervention
Effectiveness (CATIE) Investigators
The British Journal of Psychiatry (2008) 193: 279-288
3 - Cognitive markers of short-term clinical
outcome in first-episode psychosis
Michael Bodnar, Ashok Malla,
Ridha Joober, Martin Lepage
The British Journal of Psychiatry (2008) 193: 297-304
3! - Schizophrenia and offspring's risk for
adverse pregnancy outcomes and infant death
Emma Nilsson, Christina M. Hultman, Sven Cnattingius,
The British Journal of Psychiatry (2008) 193: 311-315
3! - Does
stimulation of 5-HT1A receptors improve cognition in schizophrenia?
Herbert Y. Meltzer and Tomiki
Sumiyoshi
Behavioural Brain Research. Volume 195, Issue 1, 16
December 2008, Pages 98-102
5 -
Neuropsychological course in the prodrome and first
episode of psychosis: Findings from the PRIME
Keith A. Hawkins, Richard S.E. Keefe, Bruce K.
Christensen, Jean Addington, Scott W. Woods, Jennifer
Callahan, Robert B. Zipursky, Diana O. Perkins,
Mauricio Tohen, Alan Breier and
Thomas H. McGlashan
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 1-9
5 - A
randomized double-blind comparison of ziprasidone vs.
clozapine for cognition in patients with
schizophrenia selected for resistance or intolerance to previous treatment
Philip D. Harvey, Emilio Sacchetti,
Alessandro Galluzzo, Fabio Romeo, Barbara Gorini, Robert M. Bilder and Antony D. Loebel
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 138-143
4 -
Antipsychotic effects on estimated 10-year coronary heart disease risk in the
CATIE schizophrenia study
Gail L. Daumit,
Donald C. Goff, Jonathan M. Meyer, Vicki G. Davis, Henry A. Nasrallah,
Joseph P. McEvoy, Robert Rosenheck,
Sonia M. Davis, John K. Hsiao, T. Scott Stroup and Jeffrey A. Lieberman
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 175-187
3! - Twin
pregnancy and the risk of schizophrenia
K. Kleinhaus, S. Harlap, M.C. Perrin, O. Manor, R. Calderon-Margalit, Y. Friedlander and D. Malaspina
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 197-200
4 - The
efficacy of aripiprazole in the treatment of multiple
symptom domains in patients with acute schizophrenia: A pooled analysis of data
from the pivotal trials
John M. Kane, Sheila Assunção-Talbott,
James M. Eudicone, Andrei Pikalov,
Richard Whitehead and David T. Crandall
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 208-215
3! - Different
psychological effects of cannabis use in adolescents at genetic high risk for
schizophrenia and with attention deficit/hyperactivity disorder (ADHD)
Chris Hollis, Madeleine J. Groom, Debasis Das, Tim Calton, Alan T.
Bates, Hayley K. Andrews,
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 216-223
3! - Amisulpride the ‘atypical’ atypical antipsychotic —
Comparison to haloperidol, risperidone and clozapine
Sridhar Natesan,
Greg E. Reckless, Karren B.L. Barlow, José N. Nobrega and Shitij Kapur
Schizophrenia
Research. Volume
105, Issues 1-3, October 2008, Pages 224-235
3! - Dosing Frequency and Adherence to
Antipsychotic Medications
Paul N. Pfeiffer, Dara Ganoczy,
and Marcia Valenstein
Psychiatr Serv 59:1207-1210, October 2008
GRATIS 3! - History,
aetiology, and symptomatology of schizophrenia
Daniel T.-Y. Tsoi, Michael D. Hunter and Peter W.R. Woodruff
Psychiatry. Volume 7, Issue 10, October 2008, Pages
404-409
GRATIS 3! -
Schizophrenia: epidemiology and risk factors
Emily A. Oliver and Paul
Fearon
Psychiatry. Volume 7, Issue 10, October 2008, Pages
410-414
GRATIS 3 - The
neuropsychology of schizophrenia
Ann M. Mortimer
Psychiatry. Volume 7, Issue 10, October 2008, Pages
435-439
GRATIS 3 - Long-term course and outcome of schizophrenia
Judith Allardyce and Jim
van Os
Psychiatry. Volume 7, Issue 10, October 2008, Pages 440-442
3 - Safety Evaluation of the Concomitant Use of Clozapine
and Benzodiazepines: A Retrospective, Cross-Sectional Chart Review
BITTER, REBECCA; DEMLER,
TAMMIE LEE; OPLER, LEWIS
Journal of Psychiatric Practice. 14(5):265-270,
September 2008
3! - The
antagonistic effect of antipsychotic drugs on a HEK293 cell line stably
expressing human α1A1-adrenoceptors
Zahra Nourian,
Michael J. Mulvany, Karsten
Bork Nielsen, Darryl S. Pickering and
Torsten Kristensen
European Journal of
Pharmacology. Volume 596, Issues 1-3, 31 October 2008,
Pages 32-40
3 - Paliperidone Extended-Release for the Treatment of
Schizophrenia
Pharmacotherapy
2008. Volume: 28 | Issue: 10: 1283-1298
3 - Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
Chermá MD, Reis M, Hägg S, Ahlner J, Bengtsson F
Ther Drug Monit. 2008 Sep
26. [Epub ahead of print]
3! - Potential
Causes of Higher Mortality in Elderly Users of Conventional and Atypical
Antipsychotic Medications
Soko Setoguchi, Philip S. Wang, M. Alan Brookhart, Claire F Canning, Liljana Kaci, and Sebastian Schneeweiss
Journal of the American Geriatrics Society. Volume 56
Issue 9, Pages 1644 - 1650
3! - Minocycline as Adjunctive Therapy for
Schizophrenia: An Open-Label Study
Miyaoka,
Tsuyoshi; Yasukawa, Rei; Yasuda, Hideaki; Hayashida, Maiko; Inagaki, Takuji;
Horiguchi, Jun
Clinical Neuropharmacology.
31(5):287-292, September/October 2008
5 -
Short-term treatment with risperidone or haloperidol
in first-episode schizophrenia: 8-week results of a randomized controlled trial
within the German Research Network on Schizophrenia
Hans-Jürgen Möller, Michael Riedel, Markus Jäger, Florian Wickelmaier, Wolfgang Maier, Kai-Uwe Kühn, Gerhard Buchkremer, Isabella Heuser,Joachim Klosterkötter, Markus Gastpar, Dieter F. Braus, Ralf Schlösser, Frank Schneider, Christian Ohmann, Mathias Riesbeck and Wolfgang Gaebel for
the German Study Group on First-Episode Schizophrenia
The
International Journal of Neuropsychopharmacology
(2008), 11:985-997
3! - Maternal Iron Deficiency and the Risk
of Schizophrenia in Offspring
Beverly J. Insel, Catherine A. Schaefer, Ian W. McKeague,
Ezra S. Susser, Alan S. Brown
Arch Gen Psychiatry. 2008;65(10):1136-1144
3 - Effects of
Second-Generation Antipsychotic Medication on Smooth Pursuit Performance in
Antipsychotic-Naive Schizophrenia
Rebekka Lencer, Andreas Sprenger, Margret S. H. Harris, James L. Reilly, Matcheri
S. Keshavan, John
A. Sweeney
Arch Gen Psychiatry. 2008;65(10):1146-1154
3! - Sleep Disturbances
in Patients with Schizophrenia: Impact and Effect of Antipsychotics
Cohrs, Stefan
CNS Drugs.
22(11):939-962, 2008
3 - Remission
in the outpatient care of schizophrenia: 3-Year results from the Schizophrenia
Outpatients Health Outcomes (SOHO) Study in
Isabelle Gasquet, Josep Maria Haro, Stéphanie Tcherny-Lessenot,
European
Psychiatry. Volume 23, Issue 7, October 2008, Pages
491-496
3 - Is
Schizophrenia a Syndrome of Accelerated Aging?
Brian Kirkpatrick, Erick Messias, Philip D. Harvey,Emilio
Fernandez-Egea and Christopher R. Bowie
Schizophrenia Bulletin 2008 34(6):1024-1032
3 - Prenatal
Nutritional Deficiency and Risk of Adult Schizophrenia
Alan S. Brown and Ezra S. Susser
Schizophrenia Bulletin 2008
34(6):1054-1063
3 - Hypothesis:
Grandiosity and Guilt Cause Paranoia; Paranoid Schizophrenia is a Psychotic
Mood Disorder; a Review
Schizophrenia Bulletin 2008
34(6):1151-1162
GRATIS 3! -
Clinical, Functional, and Economic Ramifications of Early Nonresponse
to Antipsychotics in the Naturalistic Treatment of Schizophrenia
Haya Ascher-Svanum, Allen W. Nyhuis, Douglas E. Faries,Bruce
J. Kinon, Robert W. Baker and Anantha Shekhar
Schizophrenia Bulletin 2008
34(6):1163-1171
GRATIS 3 - Leptin and Ghrelin Levels in
Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
Othman Sentissi, Jacques Epelbaum, Jean-Pierre Olié andMarie-France Poirier
Schizophrenia
Bulletin 2008 34(6):1189-1199
3 - Clinical
and serotonergic predictors of non-affective acute
remitting psychosis in patients with a first-episode psychosis
B. Arranz, L. San, N. Ramírez, R. M. Dueñas, V. Perez, J. Salavert, I. Corripio, E. Alvarez
Acta Psychiatrica Scandinavica.
Published Online: 31 Aug 2008
3 -
Characterization of aripiprazole partial agonist activity
at human dopamine D3 receptors
Yoshihiro Tadori, Robert A. Forbes, Robert D. McQuade and Tetsuro
Kikuchi
European Journal of
Pharmacology. Volume 597, Issues 1-3, 12 November 2008,
Pages 27-33
3 - Remission in patients with first-episode schizophrenia receiving
assured antipsychotic medication: a study with risperidone
long-acting injection
Emsley, Robin; Oosthuizen,
Petrus; Koen, Liezl; Niehaus, Dana J.H; Medori, Rossella; Rabinowitz, Jonathan
International
Clinical Psychopharmacology. 23(6):325-331, November 2008
3! - Efficacy and safety of oral paliperidone
extended-release tablets in the treatment of acute schizophrenia: pooled data
from three 52-week open-label studies
Emsley, Robin; Berwaerts, Joris; Eerdekens, Marielle; Kramer, Michelle; Lane, Rosanne;
Lim, Pilar; Hough, David; Palumbo, Joseph
International
Clinical Psychopharmacology. 23(6):343-356, November 2008
3 - Symptomatic remission in elderly
schizophrenia patients treated with long-acting risperidone
Shelly Tadger, Yehuda
Baruch and Yoram Barak
International
Psychogeriatrics (2008), 20:1245-1250
3 - Subunit-Selective Modulation of GABA Type A
Receptor Neurotransmission and Cognition in Schizophrenia
David A. Lewis, Raymond Y. Cho, Cameron S. Carter, Kevin Eklund, Sarah Forster, Mary Ann Kelly, and Debra Montrose
Am J Psychiatry Published October 15, 2008
3! - Population
pharmacokinetic analysis for risperidone using highly
sparse sampling measurements from the CATIE study
Yan Feng, Bruce G. Pollock, Kim Coley, Stephen Marder, Del Miller, Margaret Kirshner, Manickam Aravagiri, Lon Schneider & Robert R. Bies
British Journal of Clinical Pharmacology. Volume 66
Issue 5, Pages 629 - 639
3! - Sex differences in schizophrenia and other psychotic
disorders: a 20-year longitudinal study of psychosis and recovery
, , , ,
Comp Psychiatry.
Volume 49, Issue 6, Pages 523-529 (November 2008)
3 - Taq1A
polymorphism in the dopamine D2 receptor gene as a predictor of clinical
response to aripiprazole
Jun Soo Kwon, Euitae Kim, Do-Hyung Kang, Jung Seok Choi, Kyung-Sang Yu, In-Jin
Jang, Sang-Goo Shin and APLUS study group
European Neuropsychopharmacology. Volume
18, Issue 12, December 2008, Pages 897-907
3! - The Impact of Calories and Fat Content of Meals on
Oral Ziprasidone Absorption: A Randomized,
Open-Label, Crossover Trial
Kuan Gandelman, Jeffrey A. Alderman, Paul Glue, Ilise Lombardo, Robert R. LaBadie,
Mark Versavel, and Sheldon H. Preskorn
J Clin Psychiatry
October 21, 2008: e1-e5
3! -
Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical
antipsychotics in stabilized schizophrenic patients
AM Catafau, MM Penengo, G. Nucci, S. Bullich, I. Corripio,
E. Parellada,
C. García-Ribera,
R. Gomeni,
E. Merlo-Pich,
Barcelona Clinical Imaging in Psychiatry Group
Journal
of Psychopharmacology, Vol. 22, No. 8, 882-894 (2008)
3 - The
—1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative
symptom response to risperidone treatment in
schizophrenia patients
L. Wang, C.
Fang, A.
Zhang, J. Du,
L. Yu, J. Ma, G. Feng, Q. Xing, L. He
Journal
of Psychopharmacology, Vol. 22, No. 8, 904-909 (2008)
3 -
Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme
(COMT G158A, A-278G) genes and extrapyramidal
symptoms in patients with schizophrenia and bipolar disorders
Amalia Lafuente,
Miquel Bernardo, Sergi Mas, Anna Crescenti, Monica Aparici, Patricia Gasso, Ramon Deulofeu, Anna Mane, Rosa Catalan and Xavier Carne
Psychiatry Research. Volume 161, Issue 2, 30 November 2008, Pages
131-141
3 -
Collaboration in outpatient antipsychotic drug treatment: Analysis of
potentially influencing factors
Stefan Klingberg,
Sabine Schneider, Andreas Wittorf, Gerhard Buchkremer and
Georg Wiedemann
Psychiatry Research. Volume 161, Issue 2, 30 November 2008, Pages
225-234
3! - Zonisamide
Prevents Olanzapine-Associated Hyperphagia,
Weight Gain, and Elevated Blood Glucose in Rats
Nicholas
M Wallingford, Puspha Sinnayah,
Frank P Bymaster, Kishore
M Gadde, Ranga
K Krishnan, Anthony A McKinney, Ronald P Landbloom,
Gary D Tollefson and Michael A Cowley
Neuropsychopharmacology (2008) 33, 2922–2933
3! - Asenapine
Increases Dopamine, Norepinephrine, and Acetylcholine
Efflux in the Rat Medial Prefrontal Cortex and Hippocampus
Mei Huang,
Zhu Li, Jin Dai, Mohammed Shahid, Erik
H F Wong and Herbert
Y Meltzer
Neuropsychopharmacology (2008) 33, 2934–2945
GRATIS 3 -
Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia
George M. Simpson, Cedric J. O’Gorman,
CNS Spectr.
2008;13(10):898-905
GRATIS 3! - Predictors of Remission and Recovery in a First-Episode Schizophrenia
Spectrum Disorder. Sample: 2-Year Follow-Up of the OPUS Trial
Lone Petersen, Anne Thorup, Johan Øqhlenschlæger, Torben Øqstergaard Christensen, Pia Jeppesen, Gertrud Krarup, Per Jørrgensen, Erik Lykke Mortensen, Merete Nordentoft
Can J Psychiatry
2008;53(10):660–670
5 - The
Efficacy and Tolerability of Once-Daily Extended Release Quetiapine
Fumarate in Hospitalized Patients with Acute
Schizophrenia: A 6-Week Randomized, Double-
Blind, Placebo-Controlled Study
Jean-Pierre Lindenmayer, David Brown, Sherry Liu, Martin Brecher, and Didier Meulien, on
behalf of the Study 41 investigators
Psychopharmacology Bulletin. 2008;41(3):11235
3 -
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia,
Parkinsonism and Dyskinesia
Arija Maat, Annemarie Fouwels,
Lieuwe de Haan
Psychopharmacology Bulletin. 2008; 41( 3): 5– 10
GRATIS 3 - Deficit schizophrenia: an update
BRIAN KIRKPATRICK and SILVANA GALDERISI
World Psychiatry. 2008
October; 7(3): 143–147
GRATIS 3 - Early intervention in psychosis:
concepts, evidence and future directions
PATRICK D. MCGORRY, EÓIN KILLACKEY, and ALISON YUNG
World
Psychiatry. 2008 October; 7(3): 148–156
| Regresar a RESÚMENES OCTUBRE 2008 |